Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 37.88B | 35.17B | 31.76B | 31.41B | 28.69B |
Gross Profit | 24.55B | 22.28B | 20.36B | 21.38B | 19.13B |
EBITDA | 15.75B | 13.37B | 13.48B | 13.97B | 12.66B |
Net Income | 7.03B | 7.79B | 9.05B | 9.11B | 8.06B |
Balance Sheet | |||||
Total Assets | 61.78B | 65.30B | 61.68B | 41.29B | 44.81B |
Cash, Cash Equivalents and Short-Term Investments | 4.22B | 3.06B | 3.21B | 4.50B | 7.28B |
Total Debt | 45.70B | 47.91B | 43.12B | 27.81B | 31.54B |
Total Liabilities | 71.65B | 74.75B | 67.99B | 49.50B | 55.45B |
Stockholders Equity | -11.75B | -11.22B | -8.96B | -10.11B | -12.57B |
Cash Flow | |||||
Free Cash Flow | 10.77B | 7.88B | 9.73B | 11.22B | 9.21B |
Operating Cash Flow | 12.22B | 9.20B | 10.80B | 11.97B | 9.81B |
Investing Cash Flow | -1.09B | -3.60B | -15.68B | -2.36B | -1.15B |
Financing Cash Flow | -9.48B | -5.58B | 3.81B | -11.98B | -8.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | 1.40B | 13.70 | 6.52% | 5.78% | 4.11% | -15.50% | |
71 Outperform | 110.05B | 12.66 | -269.87% | 6.44% | -0.18% | -10.69% | |
70 Outperform | 3.13B | 31.27 | 3.45% | 0.31% | 61.64% | 16.76% | |
70 Neutral | 1.84B | 42.63 | 19.97% | 0.29% | 4.44% | -5.94% | |
67 Neutral | $251.61B | 30.67 | -37142.11% | 3.34% | 7.44% | -6.72% | |
62 Neutral | 121.02B | 31.01 | 6.18% | 5.43% | 0.48% | 0.00% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
On September 2, 2025, Philip Morris International participated in the Barclays Global Consumer Staples Conference, where CEO Jacek Olczak reaffirmed the company’s 2025 full-year EPS forecast, projecting a growth of 13% to 15% in adjusted diluted EPS. Despite increasing competition in smoke-free products, PMI reported strong growth in its IQOS and ZYN products, with significant momentum in the U.S. market. The company highlighted better-than-expected volume dynamics in Turkey and Egypt and continued strong international growth for its smoke-free products.
The most recent analyst rating on (PM) stock is a Hold with a $185.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.